Study record managers: refer to the Data Element Definitions if submitting registration or results information

Study record managers: refer to the Data Element Definitions if submitting registration or results information

Presbycusis, Hearing Loss, Sensorineural, Noise Induced Hearing Loss Trial in United States (FX-322, ) · Hearing Loss, Sensorineural, Noise Induced Hearing Loss, Sudden Hearing Loss Trial in United States (FX-322, Placebo)

Study record managers: refer to the Data Element Definitions if submitting registration or results information

322(MXN) Mexican Peso(MXN) To United States Dollar(USD) Currency Rates Today - FX Exchange Rate

This is a Phase 1b, prospective, randomized, double-blind, placebo-controlled, single-dose, multicenter, safety study of FX-322, administered by intratympanic injection, in adults with severe sensorineural hearing loss.

Sensorineural hearing loss (SNHL) accounts for about 90% of all cases of hearing loss. The study will assess the safety of FX-322 given as a single intratympanic injection in subjects with a medical history of sensorineural hearing loss that is associated with noise exposure or sudden hearing loss.

May 31, 2024 - How much CNY is 322 USD? Check the latest CNY price in USD! United States Dollar to Chinese Yuan Currency Exchange Rate by Walletinvestor.com

322 NZD to FJD - FX Currency Exchange Rate. #322NZD #NZD #FJD #NZDFJD

Is anyone familiar with Frequency Therapeutics and FX 322? Their pill FX322 is in clinical trials to restore hearing loss.

Find the latest Frequency Therapeutics, Inc. (FREQ) stock quote, history, news and other vital information to help you with your stock trading and investing.

We cannot provide a description for this page right now